What is the stock symbol for Praxair (PX)?
Praxair trades on the New York Stock Exchange (NYSE) under the ticker symbol "PX.". Praxair, Inc. (NYSE:PX) issued its earnings results on Thursday, October, 26th. The basic materials company reported $1.50 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.44 by $0.06.
Is Praxair owned by institutional investors?
Only 7.88% of the stock of Praxair is held by institutions. Earnings for Praxair are expected to grow by 47.27% in the coming year, from $0.55 to $0.81 per share. Is Praxair a buy right now?
Is Praxair (Prax) a good buy on Wall Street?
Praxair has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $17.50, Praxair has a forecasted upside of 31.6% from its current price of $13.30.
Why did Air Products & Chemicals stock fall 11% Thursday?
Shares of Air Products & Chemicals ( APD -1.45% ) fell more than 11% in early trading Thursday after the industrial gases producer reported a small earnings miss but beat on fiscal Q1 2021 sales. Analysts had forecast Air Products would earn $2.19 per share (adjusted) on sales of $2.35 billion.
What happened Praxair stock?
Shares of Praxair (NYSE: PX) will cease trading at the close of the New York Stock Exchange on 30 October 2018 and trading in Linde plc shares is expected to commence on the New York Stock Exchange on 31 October 2018 under the stock ticker symbol “LIN”. Linde plc will seek inclusion in the S&P 500 and DAX 30 indices.
How much is Praxair worth?
PraxairTypeSubsidiary of Linde plcRevenueUS$11.437 billion (2017)Operating incomeUS$2.448 billion (2017)Net incomeUS$1.237 billion (2017)Total assetsUS$20.436 billion12 more rows
Should I buy PX stock?
There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Praxair stock.
Why Linde stock is worth a look?
Rotonti: Linde is the largest industrial gas company in the world. It generates about $28 billion in sales, has a market cap of $148 billion. It does have net debt of $11.6 billion, so its enterprise value is about $160 billion. But its balance sheet is very strong, which we can get into.
Did Linde buy Praxair?
Linde (Dublin, Ireland) announced in August 2020 that its U.S. subsidiary, Praxair, Inc. (Danbury, Conn., U.S.), will begin operating under the Linde name, effective Sept. 1, 2020. This name change reflects the company's evolution following the merger of Praxair, Inc.
Did Airgas buy Praxair?
In December, Praxair Inc., based in Danbury, Connecticut, made an offer to acquire German company Linde Group. The transaction, valued at $35.6 billion, follows the purchase in 2016 of U.S.-based Airgas Inc. by France's L'Air Liquide SA for $13.4 billion.
Is P10 a good stock to buy?
If you are looking for stocks with good return, P10 Inc. stock can be a bad, high-risk 1-year investment option. P10 Inc. real time quote is equal to 11.680 USD at 2022-05-26, but your current investment may be devalued in the future.
Can you buy stock in helium?
In order to buy shares in Helium One. you need to open an account with a trading platform. We work with a wide number of trading platforms (see below), and you can choose the one which is right for you. You will need to provide ID and bank account information to open a trading account.
What is Dow Chemical stock price?
$51.69$ 51.66CloseChgChg %$51.690.080.16%
Who is bigger Linde or Air Liquide?
Air Liquide's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Air Liquide. Their current valuation is $6.71B. The Linde Group's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of The Linde Group....Air Liquide vs The Linde Group.48%Promoters17%Passive35%Detractors
Is Linde overvalued?
In short, The stock of Linde PLC (NYSE:LIN, 30-year Financials) is estimated to be significantly overvalued. The company's financial condition is fair and its profitability is strong. Its growth ranks in the middle range of the companies in Chemicals industry.
Is Linde PLC a good investment?
Conclusion. Linde is a great company. It is a market leader in the industrial gases segment, and it offers products across industries and markets. Its fundamentals are extremely impressive, and the company has significant growth opportunity in the coming future.
Should I buy or sell Praxair stock right now?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Praxair in the last year. There are currently 5 buy ratings for the stock....
What is Praxair's stock price forecast for 2022?
5 brokers have issued twelve-month price objectives for Praxair's stock. Their forecasts range from $13.00 to $18.00. On average, they predict Prax...
Are investors shorting Praxair?
Praxair saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 947,300 shares, an increase of 59.3...
When is Praxair's next earnings date?
Praxair is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Praxair .
How were Praxair's earnings last quarter?
Praxair, Inc. (NYSE:PX) posted its quarterly earnings results on Thursday, May, 12th. The basic materials company reported $0.18 earnings per share...
How often does Praxair pay dividends? What is the dividend yield for Praxair?
Praxair announced a quarterly dividend on Thursday, May 12th. Shareholders of record on Tuesday, May 31st will be given a dividend of $0.03 per sha...
Is Praxair a good dividend stock?
Praxair(NYSE:PX) pays an annual dividend of $0.12 per share and currently has a dividend yield of 1.14%. View Praxair's dividend history .
What guidance has Praxair issued on next quarter's earnings?
Praxair issued an update on its first quarter earnings guidance on Thursday, May, 12th. The company provided earnings per share guidance of $0.18 f...
Who are Praxair's key executives?
Praxair's management team includes the following people: Mr. Stephen F. Angel , Chairman & CEO (Age 62) Mr. Matthew J. White , Sr. VP & CFO (A...
What happened
Shares of Air Products & Chemicals ( APD -1.45% ) fell more than 11% in early trading Thursday after the industrial gases producer reported a small earnings miss but beat on fiscal Q1 2021 sales. Analysts had forecast Air Products would earn $2.19 per share (adjusted) on sales of $2.35 billion.
So what
Air Products reported earnings per share of $2.12, both pro forma and when calculated according to generally accepted accounting principles ( GAAP ). These earnings declined 1% year over year whichever way you calculate them, instead of rising as analysts had hoped.
Now what
Management did not provide guidance for the year ahead, aside from saying that "we remain confident in the profitable growth strategy we are executing." Analysts, meanwhile, continue to forecast a rebound in earnings this year, predicting full-year fiscal 2021 profits will rise 11% to $9.31 per share on 8% sales growth to $9.6 billion.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
NYSE: PFE
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
NYSE: PFE
So why are these vaccine stocks tumbling today? Investors appear to be looking past the current surge in COVID-19 cases and expect a future where fewer vaccine doses are administered.
So what
Investors should always look forward. And the number of COVID-19 vaccine doses sold by Pfizer, BioNTech, and Moderna could very well decline significantly after 2022 (or perhaps 2023).
Now what
Cuba Gooding, Jr.'s character in the movie Jerry Maguire had a famous line that seems applicable for Pfizer, BioNTech, and Moderna: "Show me the money." The main thing for investors to watch with all three companies is the money -- in particular, supply deals for COVID-19 vaccines for beyond 2022.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
